
7.45 Delayed Data As of Jan 27 | ![]() Today’s Change | 3.65 Today|||52-Week Range 42.63 | +50.81% Year-to-Date |
Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
---|---|---|---|---|---|---|
Harkness James | ![]() | 3/15/2022 | 34,919 | $19.74 | $689.3K | -63.27% |
Beattie John Gregory Chief Operating Officer | ![]() | 9/09/2022 | 8,900 | $22.34 | $198.8K | -66.53% |
Beattie John Gregory Chief Operating Officer | ![]() | 2/16/2022 | 5,800 | $23.71 | $137.5K | -68.33% |
Taylor Beth A /endocyte/ Chief Financial Officer & Vice President | ![]() | 2/18/2022 | 5,000 | $23.07 | $115.4K | -67.88% |
Beattie John Gregory Chief Operating Officer | ![]() | 2/17/2022 | 4,600 | $21.19 | $97.5K | -63.18% |
Harkness James | ![]() | 3/15/2022 | 4,049 | $18.84 | $76.3K | -63.27% |
Pitchford William D Chief Human Resources Officer | ![]() | 2/18/2022 | 3,500 | $21.12 | $73.9K | -67.88% |
Davis Gregory C /bioanalytical / Director | ![]() | 2/18/2022 | 2,500 | $23.93 | $59.8K | -67.88% |
Downing Philip A | ![]() | 2/22/2022 | 2,000 | $23.97 | $47.9K | -70.89% |
Davis Gregory C /bioanalytical / Director | ![]() | 2/18/2022 | 1,250 | $21.12 | $26.4K | -67.88% |